Imperial College London


Faculty of MedicineDepartment of Surgery & Cancer

Professor of Cancer Biology



charlotte.bevan Website




Mrs Suzy Ford +44 (0)20 7594 2135




139ICTEM buildingHammersmith Campus






BibTex format

author = {Pine, AC and Fioretti, FF and Brooke, GN and Bevan, CL},
doi = {10.12688/f1000research.8019.1},
journal = {F1000 Research},
title = {Advances in genetics: widening our understanding of prostate cancer},
url = {},
volume = {5},
year = {2016}

RIS format (EndNote, RefMan)

AB - Prostate cancer is a leading cause of cancer-related death in Western men. Our understanding of the genetic alterations associated with disease predisposition, development, progression, and therapy response is rapidly improving, at least in part, owing to the development of next-generation sequencing technologies. Large advances have been made in our understanding of the genetics of prostate cancer through the application of whole-exome sequencing, and this review summarises recent advances in this field and discusses how exome sequencing could be used clinically to promote personalised medicine for prostate cancer patients.
AU - Pine,AC
AU - Fioretti,FF
AU - Brooke,GN
AU - Bevan,CL
DO - 10.12688/f1000research.8019.1
PY - 2016///
SN - 2046-1402
TI - Advances in genetics: widening our understanding of prostate cancer
T2 - F1000 Research
UR -
UR -
VL - 5
ER -